SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-050900
Filing Date
2018-09-13
Accepted
2018-09-13 17:11:42
Documents
1
Period of Report
2018-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9915
  Complete submission text file 0001209191-18-050900.txt   12041
Mailing Address 2710 SAND HILL ROAD SUITE 100 MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SUITE 100 MENLO PARK CA 94025 650-388-7600
MORGENTHALER VENTURE PARTNERS IX LP (Reporting) CIK: 0001439101 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-38653 | Film No.: 181069458

Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3200 ALPINE ROAD PORTOLA VALLEY CA 94028
Business Address 3200 ALPINE ROAD PORTOLA VALLEY CA 94028 650-388-7600
Morgenthaler Management Partners IX, LLC (Reporting) CIK: 0001666860 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38653 | Film No.: 181069459